Company · CIK 2007919
Inhibrx Biosciences, Inc.
| CIK | 2007919 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | CA |
| Listed | INBX (Nasdaq) |
| First annual or quarterly report | 2024-08-13 |
Offerings
1 registration| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-280127 | 2024-06-11 | 2025-06-04 | 4 |
Filings
5| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2025-06-04 | EFFECTDeclared effective | 333-280127 | 9999999995-25-001825 |
| 2025-04-18 | EFFECTDeclared effective | 333-280127 | 9999999995-25-001146 |
| 2024-06-18 | EFFECTDeclared effective | 333-280127 | 9999999995-24-001886 |
| 2024-06-11 | S-1Registration filed | 333-280127 | 0002007919-24-000011 |
| 2024-01-29 | DRSDraft made public | 377-07073 | 0001104659-24-007392 |